These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures. White A, Berman S, Lowenthal JP. Appl Microbiol; 1972 May; 23(5):951-2. PubMed ID: 4624213 [Abstract] [Full Text] [Related]
3. Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures. White A, Berman S, Lowenthal JP. Appl Microbiol; 1971 Nov; 22(5):909-13. PubMed ID: 5132097 [Abstract] [Full Text] [Related]
4. [Properties of rubella virus hemagglutinin treated with Tween 80 and ethyl ether]. Laufs R, Thomssen R. Arch Gesamte Virusforsch; 1968 Nov; 24(3):164-80. PubMed ID: 5698886 [No Abstract] [Full Text] [Related]
5. Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues. Harrison VR, Binn LN, Randall R. Am J Trop Med Hyg; 1967 Nov; 16(6):786-91. PubMed ID: 4965219 [No Abstract] [Full Text] [Related]
6. Immunogenicity of purified, inactivated chikungunya virus in monkeys. Nakao E, Hotta S. Bull World Health Organ; 1973 May; 48(5):559-62. PubMed ID: 4204490 [Abstract] [Full Text] [Related]
7. Production and evaluation of a formalin-killed Chikungunya vaccine. Harrison VR, Eckels KH, Bartelloni PJ, Hampton C. J Immunol; 1971 Sep; 107(3):643-7. PubMed ID: 4999088 [No Abstract] [Full Text] [Related]
8. Large-scale purification of rubella virus and preparation of an experimental split rubella virus vaccine. Väänänen P, Vaheri A. Appl Microbiol; 1971 Sep; 22(3):255-9. PubMed ID: 5119198 [Abstract] [Full Text] [Related]
9. Density gradient characterization of disrupted and untreated eastern encephalitis virus. Karabatsos N. Arch Gesamte Virusforsch; 1973 Sep; 40(3):222-35. PubMed ID: 4735530 [No Abstract] [Full Text] [Related]
13. Yellow fever vaccine. IV. Reactogenicity and antibody response in volunteers inoculated with a vaccine free from contaminating avian leukosis viruses. Tauraso NM, Coultrip RL, Legters LJ, Richman AV, Rosenberg DM, Savadge TO, Shelokov A, Spector SL, Trimmer RW. Proc Soc Exp Biol Med; 1972 Feb; 139(2):439-46. PubMed ID: 4333781 [No Abstract] [Full Text] [Related]
14. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. Tiwari M, Parida M, Santhosh SR, Khan M, Dash PK, Rao PV. Vaccine; 2009 Apr 21; 27(18):2513-22. PubMed ID: 19368794 [Abstract] [Full Text] [Related]
15. SEPARATION OF MEASLES VIRUS COMPONENTS BY EQUILIBRIUM CENTRIFUGATION IN CSCL GRADIENTS. I. CRUDE AND TWEEN AND ETHER TREATED CONCENTRATED TISSUE CULTURE MATERIAL. NORRBY E. Arch Gesamte Virusforsch; 1964 Apr 21; 14():306-18. PubMed ID: 14181216 [No Abstract] [Full Text] [Related]
16. Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures. Chappell WA, Halonen PE, Toole RF, Calisher CH, Chester L. Appl Microbiol; 1969 Sep 21; 18(3):433-7. PubMed ID: 5392898 [Abstract] [Full Text] [Related]
18. Studies on rubella virus hemagglutination. I. Activation by various treatments. Sato H. Arch Gesamte Virusforsch; 1971 Sep 21; 35(2):256-68. PubMed ID: 5002908 [No Abstract] [Full Text] [Related]